Concepedia

Wibke Lembke

WL

Statistics

Publications

2

Citations

61

H-Index

2

Active since

2022

Affiliations

Sana Biotechnology (United States)(Current)

AbbVie (United States)

Janssen (United States)

Bristol-Myers Squibb (United States)

BioMarin (United States)

Wibke Lembke is an author at Sana Biotechnology (United States) specializing in immunogenicity of gene therapies, medicine, and gene delivery.

Publications per year

2022–2024

2

Publications

2

2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 &amp; CAR-T Immunogenicity; PCR &amp; Vaccine Assay Performance; ADA Assay Comparability &amp; Cut Point Appropriateness ( <u>Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)

LiNa Loo, Shannon Harris, Mark Milton et al. · Bioanalysis · 2022 · 36 citations · Full text

, , +16

Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirements

Manuela Braun, Claudia Lange, Philipp Schatz et al. · Molecular Therapy — Methods & Clinical Development · 2024 · 25 citations · Full text

, , +17

1–2 of 2